Plain-English translation of NCT05545007 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing hypofractionated radiosurgery (a focused type of radiation therapy given over a few days) for patients with large brain metastases (cancer that has spread to the brain) that need surgery. The study compares two approaches: receiving this radiation before surgery versus after surgery. The goal is to find the best timing and approach to control the cancer while minimizing side effects and complications.
Large brain metastases are difficult to treat, and surgery alone often isn't enough to prevent cancer from coming back. Doctors have traditionally used whole-brain radiation after surgery, but this can damage healthy brain tissue and cause memory and thinking problems. This trial is testing whether the new radiation approach—given before or after surgery—can control cancer better while causing fewer of these serious side effects.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to the preoperative group, you will receive focused radiation therapy over 3 days, then have surgery within 1 week. If you are assigned to the postoperative group, you will have surgery first, then receive the same focused radiation therapy 4 to 6 weeks later. Both groups receive the same total radiation dose (27 Gray) divided into 3 daily treatments. You will need follow-up appointments and imaging scans to monitor how well the treatment is working and watch for any side effects.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Italy